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Abstract: 
Objective: Adjuvant protocols devised to enhance motor recovery in subacute stroke patients 
have failed to show benefits with respect to classic therapeutic interventions. Here we evaluate 
the efficacy of a novel brain-state dependent intervention based on known mechanisms of 
memory and learning, that is integrated as part of the weekly rehabilitation program in subacute 
stroke patients. 
Methods: Twenty-four hospitalized subacute stroke patients were randomly assigned to two 
intervention groups; 1. The associative group received thirty pairings of a peripheral electrical 
nerve stimulus (ES) such that the generated afferent volley arrived precisely during the most 
active phase of the motor cortex as patients attempted to perform a movement; 2. In the control 
group the ES intensity was too low to generate a stimulation of the nerve. Functional (including 
the lower extremity Fugl-Meyer assessment (LE-FM; primary outcome measure)) and 
neurophysiological (changes in motor evoked potentials (MEPs)) assessments were performed 
prior to and following the intervention period. 
Results: The associative group significantly improved functional recovery with respect to the 
control group (median (interquartile range) LE-FM improvement: 6.5 (3.5-8.25) and 3 (0.75-3), 
respectively; p=0.029). Significant increases in MEP amplitude were seen following all sessions 
in the associative group only (p’s≤0.006). 
Interpretation: This is the first evidence of a clinical effect of a neuromodulatory intervention 
in the subacute phase of stroke. This was evident with relatively few repetitions in comparison to 
available techniques, making it a clinically-viable approach. The results indicate the potential of 
the proposed neuromodulation system in daily clinical routine for stroke rehabilitation. 
Keywords: Stroke, Cortical, Plasticity  
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Introduction 
In recent years, several adjuvant therapies based on non-invasive brain stimulation (NIBS, for 
review see1) have been devised for enhancing the spontaneous biological recovery process 
following stroke1,2. The basic assumption is that NIBS ‘primes’ the motor cortex for subsequent 
learning, which then occurs during a period of increased cortical excitability. However, the 
benefits of NIBS on function or motor learning are relatively small3 and the responses highly 
variable between and within patients. The source of this variability remains unclear, but may be 
related to the diffuse set of cortical neurons activated by NIBS which exhibit either inhibitory or 
excitatory actions onto the motor cortex4. The efficacy may thus be related to the overall state of 
excitability of the cortical network, referred to as the brain state. Applying NIBS during specific 
brain states may enhance their effectiveness5. 
We have recently demonstrated that a brain state-dependent peripheral stimulation protocol 
induces significant plasticity of the damaged cortex in chronic stroke patients that translates 
directly into improved function6. Peripheral nerve stimulation is timed to arrive at the motor cortex 
during the peak negative (PN) phase of the movement-related cortical potential (MRCP), inducing 
a causal and systematic relation between the sensory signals arising from muscles involved in the 
movement and the physiologically generated brain wave during imagination or attempt of that 
movement (Fig. 1). This intervention exhibits many of the characteristics of associative long-term 
potentiation, one of the primary mechanism for memory formation and learning7,8, since its effects 
develop rapidly, are long lasting, depend on the timing of the two inputs and are specific to the 
targeted muscle9,10,11. 
One of the advantages of triggering peripheral stimulation based on the physiological activation 
of the motor cortex is the active participation of the patients12. Indeed, a very small number of 
pairings are sufficient to promote cortical plasticity when the delay is precisely timed6. This 
approach can be exploited in a brain-computer-interface (BCI) technology that detects the brain 
activation patterns of patients and triggers peripheral stimulation. Preliminary studies on healthy 
participants have shown the feasibility of this approach10,11. 
In the current study, we present for the first time the concept of brain-state dependent peripheral 
stimulation in subacute stroke patients. We hypothesized that the proposed intervention would lead 
to an increase in function of the affected limb that is directly measurable through clinical scales. 
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Further, we hypothesized an enhancement of the output of the motor cortex to the target muscle 
following a very short intervention time (ideally, even within a single session). The demonstration 
of this hypothesis would strongly support the theory that timing is critical and that associativity is 
the main physiological mechanism underlying the induced plasticity. 
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Methods 
Ethical approval 
Patient demographic data and baseline clinical evaluations are shown in Table 1. Eighteen male 
and six female patients (61.2 ± 8.2 years) participated in this study. Inclusion criteria were; age 
above 18 years, a superior division middle cerebral artery (MCA) stroke within four months of 
inclusion in the study, and the ability to follow instructions. All patients underwent 
neuropsychological assessment, with none meeting the DSM-IV criteria for diagnosis of dementia. 
Patients were excluded if they presented with concomitant neurological or other severe medical 
problems, seizure history, contraindications to transcranial magnetic stimulation (TMS), cognitive 
impairments, treatment with drugs that act on the central nervous system, cardiovascular or 
respiratory symptoms contraindicative of walking, and any other significant non-stroke-related 
impairments affecting walking. All patients were inlaid at the neurorehabilitation center at 
Neuroenhed Nord, Brønderslev, Regionshospital Nordjylland, Denmark where they received 
intensive, multidisciplinary individualized rehabilitation therapy. Participation in this study was in 
addition to all therapies delivered at the hospital and all hospital staff were blinded to the 
experimental protocol. Approval for the study was given by the Scientific Ethics Committee for 
Nordjylland, Denmark (reference no. N-20160016). The study was performed in accordance with 
the Declaration of Helsinki. 
Sample size calculations were based on pilot testing of the current protocol in three sub-acute 
stroke patients who improved 6 ± 3 points on the lower extremity Fugl-Meyer (LE-FM) motor 
performance assessment. Our control group was expected to improve by 1.5 ± 2 points 13. A power 
analysis revealed that the minimum sample size was n = 10 in each group necessary to achieve a 
statistical power of at least 95% (two-tailed ⍺ = 0.05). 
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Overall study design 
Patients were randomly allocated to one of two groups: an associative intervention group and a 
sham intervention (control) group. A posteriori validation verified that the groups matched for age 
(t(22) = 0.19, p = 0.85) and time since stroke (t(22) = 0.36, p = 0.73). Patients attended three 
intervention sessions (see ‘Interventions’) per week for four weeks for a total of twelve sessions. 
During intervention sessions one, six and 12, corticospinal output properties were assessed using 
TMS (see ‘Quantification of corticospinal output’). Immediately prior to and after the four-week 
intervention period, patients were assessed with several clinical scales by a clinician blinded to the 
experimental protocol (see ‘Clinical and behavioral measures’). 
Clinical and behavioral measures 
Assessment were made by a clinician blinded to the protocol and included the modified Ranking 
scale score (mRS)14, LE-FM motor performance assessment15, the Ashworth scale for spasticity 
(ASS) of the affected leg16 and the functional ambulation classification (FAC) scale17 and the 10-
m walk test at their fastest pace18. The choice of using only one trained clinician was based on 
previous literature that demonstrated high test-retest and interrater reliability of the mRS scale 19,20, 
LE-FM scale 21, the ASS scale 22 and the FAC scale 23. 
Movement-related cortical potential (MRCP) 
During all sessions, monopolar electroencephalographic (EEG) signals were recorded using an 
active EEG electrode system (g.GAMMAcap2, gTec, GmbH, Austria) connected to a g.USBamp 
amplifier (gTec, GmbH, Austria) from FP1, Fz, FC1, FC2, C3, Cz, C4, CP1, CP2, and Pz 
according to the standard international 10-20 system. The channel selection was based on the large 
Laplacian, with Cz as the central channel 24. The reference electrode was placed on the left or right 
earlobes and the ground electrode on Fz. A single channel surface electromyogram (EMG) was 
recorded from the tibialis anterior (TA) muscle of the affected leg to control for the patients’ 
movement. All EEG and EMG signals were sampled at a frequency of 256 Hz and hardware 
filtered from 0 to 100 Hz. 
Patients were asked to attempt 30 dorsiflexion movements of the foot contralateral to the lesion 
site in relation to a visual cue. The experimental setup and cue is depicted in Figure 1. A custom-
made Matlab script (R2014b, Mathworks®) provided this cue via a screen positioned 1.5 m in 
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front of the patient on when to mentally prepare, execute, and release the movement. Patients were 
instructed to attempt to perform a single dorsiflexion movement as fast as possible when the cursor 
had reached the upwards turn and to maintain the new position for 2 s, following which they 
relaxed again for 4-5 s prior to the next cue being provided. Data from recorded EEG signals were 
used to quantify the time of PN of the MRCP’s before proceeding to either the associative or sham 
interventions described under the section ‘Interventions’. 
Feature extraction from the MRCP 
Matlab software (R2014b, Mathworks®) was used to filter the continuous EEG signals using a 
second order band-pass filter from 0.05 to 10 Hz. EEG data were then divided into 4 s epochs 
(from 2 s before to 2 s after the visual cue) for each movement and a Laplacian channel24 was used 
to enhance the MRCP in each epoch. Next, a window of 500 ms on either side of task onset was 
chosen. If any epochs’ PN was outside the selected window it was discarded. Epochs with 
electrooculography (EOG) activity exceeding 140 µV were also discarded. The remaining epochs 
were averaged and the mean PN was defined as the time of occurrence of the minimum value of 
the averaged MRCP in relation to the visual cue. The mean PN was used to calculate the point in 
time for when to apply the peripheral stimulation in the subsequent intervention session for both 
patient groups. 
Recording and stimulation 
EMG activity was recorded by surface Ag/AgCl electrodes (20 mm Ambu Neuroline 720, Ambu 
A/S, Denmark) placed over the belly of the TA muscle affected leg25. Surface EMGs were pre-
amplified and sampled at 2 kHz using scientific software Mr. Kick II 2.3 (Knud Larsen, SMI®, 
Aalborg University, Denmark) for recordings of the motor evoked potentials (MEPs) evoked by 
TMS in the TA during sessions one, six and 12. During the intervention, EMG data were collected 
using the g.USBamps (gTec, GmbH, Austria) at a sampling frequency of 256 Hz. 
A monophasic Magstim 200 (Magstim Company, Dyfed, UK) with a focal figure of eight double 
cone coil (110 mm diameter) was used to apply single TMS pulses to elicit a MEP in the TA. The 
direction of the current was directed from posterior to anterior. MEPs were elicited before (pre), 
immediately after (post), and 30 min after (post30) the cessation of the intervention for both groups 
during intervention sessions one, six and 12. For procedure, see the section ‘Experimental 
procedures’. 
 9 
Stimulation (pulse width 1 ms) of the CPN was applied by a NoxiTest isolated peripheral 
stimulator (IES 230, Aalborg, Denmark). Stimulating electrodes (32 mm, PALS! Platinum, 
Patented Conductive Neurostimulation Electrodes, Axelgaard Manufacturing Co., Ltd. USA) were 
placed on the skin overlying the deep branch of the CPN (L4 and L5) contralateral to the lesion 
site with the cathode proximal. A suitable position for stimulation, defined as the site where a 
maximal M-wave was produced in the TA with no activity from the synergistic peroneal muscles 
and no activity from the antagonist soleus (SOL), was identified. The stimulation site corresponded 
to a point just anterior to the level of the caput fibulae. Initially, the motor threshold (MT) was 
determined as the intensity where an M-wave became visible in the EMG signal. For the 
associative intervention group, the stimulation intensity was set to MT. For the sham intervention 
group, the stimulation intensity was set to ~70% of perception threshold.  
Quantification of corticospinal output 
Patients were seated comfortably with their affected foot resting on a footplate. Initially, the 
intensity for the magnetic stimulus was set at approximately 50% of the stimulator output (SO) to 
find the optimal site for evoking a MEP in the TA. Three consecutive stimuli at a 5-7s inter-
stimulus interval, were delivered over Cz and this was repeated for different sites by moving the 
coil in ~1 cm steps anteriorly and laterally. The best spot for stimulation (also termed the hot-spot) 
was defined as the coordinate where the peak-to-peak amplitudes of the MEPs were greater in the 
target muscle than the amplitudes of adjacent coordinates for a given stimulus intensity. For all 
patients, this site was approximately 2–3 cm anterior to the vertex. Once the hot-spot was 
identified, it was marked on the patients’ head with a felt pen to ensure that the coil position was 
maintained and the stimuli were consistently delivered over the same area of the motor cortex. 
Subsequently, the resting motor threshold (RMT), defined as the highest stimulus intensity that 
produced no more than five of ten consecutive TA MEPs with a peak-to-peak amplitude of ~50 
µV while the muscle was at rest, was identified. Next, ten MEPs were elicited in the resting TA at 
each of six TMS intensities; 90, 100, 110, 120, 130, and 140% of RMT (60 MEPs in total). The 
TMS stimuli were delivered every 5–7 s in a randomized order for intensity. The mean peak-to-
peak TA MEP amplitudes were extracted pre, post, and 30 min following the cessation of the 
intervention. 
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Interventions 
For the associative group, the intervention protocol consisted of a single electrical stimulation 
delivered to the common peroneal nerve (CPN) at MT and so that the artificially generated afferent 
flow arrived at the PN of the MRCP, as outlined in our previous publications9,6. The timing was 
calculated based on the following equation: mean PN – 50 ms. The 50 ms represents the mean 
latency for the afferent inflow resulting from the peripheral stimulus to reach the somatosensory 
cortex plus a cortical processing delay and is based on previous work26. For the sham group, the 
electrical stimulus was delivered at the same time as for the associative group but at an intensity 
below motor threshold (~70%) to ensure that no afferent inflow reached the cortex at the time of 
PN. A total of 30 pairings of attempted movement according to the cue (Fig 1) and ES were applied 
during each intervention session. Patients attended a total of twelve separate intervention sessions, 
with three sessions per week over four weeks. A minimum of 24 h elapsed between sessions. 
Patients were blinded as to the intervention they received. 
Statistical analyses 
The main outcome measures were the clinical tests and the changes in MEP amplitude. Any 
differences in pre-intervention clinical measures (mRS, LE-FM, ASS, and 10-m walking test) 
between groups were evaluated with Mann-Whitney U tests. To test whether there was a change 
in clinical measures due to the interventions, separate Wilcoxon signed ranks tests were employed 
for each group for the mRS, LE-FM, ASS scores, and the 10-m walking test speed. To compare 
improvements in these clinical measures, Mann-Whitney U tests analysed the absolute pre-post 
intervention differences between the associative and sham groups. 10-m walking test speed was 
analysed using non-parametric tests because of violations to the assumption of normality. 
Bonferroni adjustments were applied to correct for multiple comparisons. A two-way between-
within ANOVA, with session (sessions one, six, 12) as the within-subjects factor and group 
(associative, sham) as the between-subjects factor, was used to evaluate RMT and the pre-
measures of TA MEPs evoked at the highest stimulation intensity across testing sessions and 
groups. Greenhouse-Geisser corrected degrees of freedom were used to correct for violations of 
the assumption of sphericity. Finally, changes in TA MEP were analysed by a repeated measures 
mixed effects ANOVA. Subject was a random effects factor nested within group (associative, 
sham) with session (sessions one, six, 12), time (pre, post, and post30), and stimulation intensity 
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(90%, 100%, 110%, 120%, 130%, 140% RMT) as within-subjects fixed factors. Post hoc Fisher’s 
least significant difference corrections were administered to determine the locus of the 
differences27. Differences with a probability of < 0.05 were considered significant. Statistical 
analyses were conducted in Minitab 18. 
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Results 
Clinical measures 
Baseline clinical scores for both groups are shown in Table 2. There were no statistically 
significant differences between the associative and sham groups for the LE-FM (95%CI: [-7, 3]), 
mRS (95%CI: [-1, 1]), FAC (95%CI: [-1, 1]), ASS (95%CI: [0, 0]), or 10-m walking speed 
(95%CI: [-0.65, 0.58] m/s; all p’s > 0.50) upon enrollment. At baseline, a total of eight patients 
presented with no visible voluntary muscle activation of the TA and were unable to perform the 
dorsiflexion movement, thirteen patients had limited dorsiflexion abilities as quantified by the LE-
FM scale, while three patients were able to perform a complete dorsiflexion movement. 
Figure 2A shows the individual and median improvements in LE-FM scores following the 
associative or sham interventions. The absolute pre-post intervention period difference scores for 
both groups are shown in Figure 2B. The associative group significantly improved in their median 
(interquartile range, IQR) lower extremity LE-FM from 23.5 (18.75–26.25) to 32 (26.25–32), Z = 
3.06, p = 0.002. The sham group also significantly improved from 25.5 (18–30) to 29.5 (21–31), 
Z = 2.63, p = 0.009. However, there was a significant median absolute pre-post intervention 
difference between the associative (6.5, 3.5–8.25) and sham (3, 0.75–3) groups, indicating that the 
associative group improved significantly more on the LE-FM compared to the sham group, Z = 
2.19, p = 0.029, 95%CI: [1, 6]. 
The associative and sham groups significantly improved in their mRS scores from 4 (3-4) to 2.5 
(2-3.3) and 4 (2.8-4) to 3 (2-3), respectively (both Z’s ≥ 2.13, both p’s ≤ 0.033), with no significant 
difference in improvements between groups (p = 0.93, 95%CI: [-1, 1]). Additionally, both groups 
equally improved their FAC score from 2 (1.8-4) to 4 (3.8-5) and 2 (1.8-4) and 4 (4-5), respectively 
(both Z’s = 2.71, both p’s = 0.007), with no difference in improvement (p > 0.99, 95%CI: [-1, 1]). 
For the ASS, no significant changes were detected for either the associative or sham groups (both 
p’s > 0.30, 95%CI: [0, 0]).  
Two patients from each of the associative and sham groups could not walk either at baseline or 
after the 4-week intervention period. There were five patients in the associative group and three 
patients in the sham group that could not walk at baseline but could walk after the four-week 
intervention period. In these instances, patients were assigned a walking speed of 0 m/s and 
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included in the statistical analyses. The associative and sham groups significantly improved their 
walking speed in the 10-m walking test from 0.59±0.77 to 1.09±0.78 m/s and 0.63±0.67 to 
0.95±0.75 m/s, respectively (both Z’s ≥ 2.67, both p’s ≤ 0.008), with no difference in improvement 
between groups (p = 0.56; 95%CI: [-0.21, 0.56] m/s). 
Reliability of the MRCP 
The associative intervention as applied in the current study requires the MRCP to be stable within 
a session, since the arrival of the afferent inflow to the motor cortex has to occur at the precise 
time of the PN phase of the MRCP. However, since each session commenced with the 
identification of the occurrence of the time of PN of the MRCP, variability across days is expected 
and may even be a further marker for plasticity induction. The two upper panels of Figure 3 show 
the time of occurrence of the PN of the MRCP for each session for two patients. Also shown are 
the standard deviations. The lower panel displays the average PN time across all sessions for each 
patient in the associative group. Across all patients, the time of PN of the MRCP occurred at -60 
±55 ms prior to the cue to commence the movement. 
Changes in corticospinal output properties 
Because of patients’ compliance to TMS, it was not always possible to elicit MEPs. For session 
one, 11/12 patients were included in the analyses from each group. For session six, 7/12 associative 
group patients and 8/12 sham group patients were included in the analyses, and for session 12, 
11/12 associative group patients and 10/12 sham group patients were included. The RMT did not 
change before or after the training for either group. For the associative group, the mean (± SD) 
RMT was 56.8±16.6%, 59.0±13.3%, and 53.9±9.5% MSO in sessions 1, 6, and 12, respectively. 
For the sham group, the mean RMT was 49.2±12.3%, 48.1±11.2%, and 53.3±13.3% MSO in 
sessions 1, 6, and 12, respectively. A two-way between-within participants ANOVA revealed no 
significant interaction between group and session (p = 0.14), nor main effect of session (p = 0.95) 
or group (p = 0.23). In patient A05, the RMTs were 84 and 73% MSO for session one and six 
respectively and for patients A07 it was 79% MSO for session one. Thus, it was not possible to 
obtain a complete recruitment curve up to 140% RMT on these occasions. 
The amplitude of the TA MEPs evoked at the highest stimulation intensity before the 
commencement of the intervention sessions across all patients attained values of 323±182 µV, 
303±220 µV, and 425±224 µV for the associative group and 471±299 µV, 382±306 µV, and 
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454±500 µV for the sham group for sessions one, six, and 12, respectively. There was no 
significant session by group interaction, nor any main significant effects of session or group (all 
p’s > 0.52), indicating that the maximal pre-intervention session MEPs did not change 
systematically throughout the intervention period. 
Figure 4 shows the mean TA MEP amplitude for the patients in the associative (Figure 4A-C) and 
sham group (Figure 4D-F), plotted against TMS intensity for intervention sessions one, six, and 
12. Data are expressed as a fraction of the maximum TA MEP amplitude prior to the intervention 
of the respective session. The linear mixed model analysis on TA MEP amplitudes revealed no 
significant four or three-way interactions between session, time, stimulation intensity, or group 
(all p’s > 0.80). However, there was a significant two-way interaction between time by group, 
F(2,964) = 3.72, p = 0.024 (Figure 4G). Following the significant group by time interaction, post hoc 
analyses revealed that, for the associative group, TA MEP amplitudes were significantly larger 
immediately post (291±214 µV) and 30 minutes post-intervention (323±275 µV) compared with 
pre-intervention values (243±241 µV), regardless of testing session and stimulation intensity (p = 
0.006, 95%CI: [13, 80] µV and p < 0.001, 95%CI: [43, 110] µV, respectively). There was no 
difference between post and post30 MEP amplitudes (p = 0.076, 95%CI: [-3, 63] µV). For the 
sham group, there were no differences in TA MEP amplitudes between pre (233±232 µV), post 
(222±219 µV), and post30 (219±239 µV) measurements across testing sessions and stimulation 
intensities (pre-post: p = 0.97, 95%CI: [-33, 32] µV; pre-post30: p = 0.38, 95%CI: [-18, 47] µV; 
post-post30: p = 0.36, 95%CI: [-17, 47] µV). 
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Discussion  
This is the first systematic study on subacute stroke patients that explicitly explores the associative 
long-term potentiation theory within a brain-state dependent rehabilitation approach. Patients 
enrolled in the associative intervention improved motor function significantly more compared with 
the sham group. The implications are that the intervention presented here has the potential to boost 
recovery beyond the spontaneous biological recovery processes in the first few months after the 
insult. Further, it opens the possibility to develop an online BCI system for patients where the 
intention to move is detected from continuous monitoring of the brain signals and used to trigger 
the peripheral stimulation that generates the afferent feedback to the brain at the precise time of 
the PN phase of the MRCP. This online BCI has been tested in healthy participants where it led to 
significant increases in the excitability of the cortical projections to the target muscle10,11. In the 
current study, we specifically tested the scientific hypothesis of associative plasticity without the 
BCI component to eliminate confounding factors (such as the fact that different patient groups 
may have different detection accuracy). Nonetheless, the current results have direct implications 
for a future BCI system that allows stroke patients to control their own recovery process. 
To date, clinical studies on the use of BCI for stroke therapy have involved chronic patients. 
Although this choice simplifies the study design because of the stable conditions of the patients, a 
real impact in stroke therapy can only be achieved in the acute and subacute phase of the stroke. 
This is the time window critical for recovery since the greatest gains are achieved in this interval28. 
During this time, genes and proteins for synaptogenesis, neuronal growth and dendritic sprouting, 
are expressed to a greater extent following a stroke29. It is in this state that the brain is highly 
plastic and it is likely that the same synaptic rules for learning and memory formation will lead to 
the most optimal outcome28. Addressing patients in this time window is extremely challenging for 
neurotechnology developments because of the variability of symptom distribution and symptom 
severity28 as well as limited patient compliance and variability in brain electrical activity. These 
conditions impose strong constraints in the development of the technology as proposed here since 
it relies on the accurate and early detection of movement intention from EEG signals. While 
chronic stroke patients exhibit rather stable MRCPs between days6, this is not the case for subacute 
stroke patients (Figure 3). This necessitates the collection of a training data set prior to the 
associative intervention where patients attempt the motor task in a number of repetitions. However, 
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in the proposed intervention, each session only requires a maximum of 20-25 minutes which 
includes the preparation time. This is well within the time-frame typically used for other 
therapeutic procedures. In this way, our approach is easily transferred into the clinical setting. 
Neural repair following stroke specifically involves adjacent sites around the lesion as well as 
remote sites that are connected to the damaged area30. Generally, the increased activity in remote 
sites as well as increased activity in the contralesional hemisphere during motor execution declines 
with recovery and the degree of this decline is correlated with the amount of function regained31. 
Within the time window of spontaneous biological recovery, significant axonal sprouting occurs 
that has the potential to be the target for novel therapies, although not all sprouting processes are 
beneficial32. The intent of the associative intervention as presented here is thus to guide plasticity 
by directly activating specific pathways known to be dysfunctional following a stroke. By 
repetitively pairing the intent of the patient, as quantified by the MRCP, with the artificially 
generated afferent inflow to the ipsilesional motor cortex, the associative intervention directly 
follows the principles of memory formation and learning first proposed by Hebb33. This targeted 
plasticity induction significantly improved functionality, and may thus promote beneficial 
plasticity processes such as axonal sprouting between those cortical areas that should be connected 
and between peripheral sensory receptors and cortical areas28. Indeed, sensory information from 
muscle receptors plays an integral part in motor learning34. The fact that the patients exposed to 
the associative intervention improved significantly more than the sham group supports the 
importance of the correct pairing in time of the peripherally generated signal and the MRCP. It 
should be noted that there were no significant improvements in the secondary functional outcome 
scores, i.e. the ASS or mRS. This is in agreement with previous reports 6,13,35. The reasons for the 
lack of improvements in these functional outcome scores remain speculative but, at least in the 
current study it can be partly explained by the fact that only two patients presented with spasticity 
at enrolment.  
The rationale of the proposed intervention is similar to that underlying paired associative 
stimulation (PAS – for review see36). PAS uses a peripherally generated afferent volley, as in our 
approach, and combines it with a second stimulation to the area of the motor cortex representing 
the target muscle with TMS. The inter-stimulus interval is such that the afferent volley arrives just 
prior to the TMS stimulus. However, PAS is not as effective as our intervention since 
approximately 50% of participants do not exhibit the expected change in excitability following 
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PAS36. The lower efficacy of PAS may be due to a diffuse activation by TMS of a set of both 
inhibitory and excitatory cortical neurons. In agreement with this interpretation, NIBS protocols 
that use either TMS or direct transcranial current stimulation have shown large variability in their 
effects, between individuals as well as within individuals across days1. In our approach, the 
activation of the cortical areas occurs naturally through the patient’s own attempt at performing 
the movement and thus the relevant brain areas are activated in a more natural manner. However, 
what remains to be investigated is the exact site of plasticity induction. Thus, in the current study, 
the significant functional improvements as quantified by the LE-FM scale and the 10 m walk test, 
were accompanied by significant increases in MEP size only in the associative group. While this 
is an indication of plastic changes within the corticospinal tract 37,38, in future studies it will be 
important to identify the exact locus of these changes and thus the associated functional changes 
using techniques such as resting functional magnetic resonance imaging or diffusion weighted 
images 38. 
The MRCP and the time of the PN of the MRCP varied from one session to the next for individual 
patients. Although this variability was reduced for single trials within a single intervention session, 
values still ranged between 150 and 300 ms. In the conventional PAS protocol, a difference of 
only 5 ms between the timing of the two stimuli could induce an inhibitory rather than a facilitatory 
effect39. Thus, although our associative intervention is modelled on PAS, it is unlikely that the two 
interventions have the same sites for plasticity induction. Irrespective of the exact site, one factor 
that is likely to contribute to the enhanced effect of our protocol as compared to PAS is that it is a 
behavioral training where the patient is actively involved in the intervention. The patient 
engagement combined with the correlated activation of the relevant brain areas through the 
peripherally generated volley and the MRCP lead to beneficial effects that are not seen in the sham 
intervention. 
Since the patients investigated here were hospitalized, one important goal during the development 
of the associative intervention was that it had to be complementary to the other activities the 
patients had to perform as part of the standard rehabilitation procedures in Denmark. Typically, 
patients at this stage have difficulty to concentrate for long periods of time and experience more 
fatigue as compared to chronic stroke patients. The associative intervention introduced here, 
requires only 30 movements to be performed in the initial phase where the PN of the MRCP is 
established, and 30 in the actual intervention phase. The total duration of a single session that 
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includes preparation of the EEG and stimulation electrodes is 20 minutes. It thus paves the way 
for this novel technology to be used within the daily clinical practice. 
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Figure Legends 
Figure 1. Schematic of the experimental set-up. Schematic of the associative and sham 
interventions performed during each of the 12 intervention sessions (three times per week for 
four weeks). Patients watched a screen placed 2 m in front of them on which a cue provided 
information on when to attempt the dorsiflexion movement. FOCUS appeared on the screen 
initially followed by the schematic of a step function. Patients were required to start the 
attempted movement once the moving cursor (triangle) reached the upward slope. Finally, the 
word REST appeared last on the screen prior to the start of the next trial. Relevant brain activity 
was measured, detected and the time of the peak negative (PN) phase of the MRCP extracted in 
the first 30 trials. In the subsequent 30 trials, this time was used to provide into an output 
command for an electrical stimulator. The stimulator applied a single pulse (1-ms duration) to 
the deep branch of the common peroneal nerve (CPN). For the associative intervention group, 
the induced sensory signal produced by the electrical stimulation applied to the CPN was timed 
to arrive at the motor cortex during the time of maximum activation of the motor cortex as seen 
in the electroencephalographic (EEG) signal. The stimulation intensity was set to 1 x motor 
threshold (MT). For the sham intervention group, the stimulation intensity was set below 
perception threshold such that there would be no resultant afferent volleys sent to the cortex. 
Thirty such pairs were performed. 
Figure 2. Lower extremity Fugl-Meyer (LE-FM) motor performance scores improved 
significantly for both associative and sham intervention groups, with a greater overall 
improvement for the associative group. A) LE-FM motor performance scores for all 
associative (grey circles) and sham (grey squares) patients pre- and post-intervention. Black 
circles and black squares represent median scores for the associative and sham groups, 
respectively. B) Pre-post intervention absolute difference scores for all associative (grey circles) 
and sham (grey squares) patients. The black circle and black square represent median absolute 
pre-post intervention difference scores for the associative and sham groups, respectively. *, p < 
0.05, **; p < 0.01. 
Figure 3. The time of peak negativity of the movement-related cortical potential (MRCP) 
across all 12 intervention sessions for the associative group. (A-B) data for single patients and 
each intervention session. Error bars represent standard deviations across all trials within a single 
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session. (C) Mean data across all sessions for each patient. Error bars represent standard 
deviations for all 12 sessions. 
Figure 4. Mean tibialis anterior (TA) motor evoked potential (MEP) recruitment curves for 
associative and sham intervention groups for sessions one, six, and 12. Recruitment curve 
properties of the TA MEP before (black squares), immediately after (grey circles), and 30 
minutes after (white triangles) the cessation of the associative (A-C) or sham (D-F) interventions 
across all participants. TA MEP amplitude is expressed as a fraction of the maximum peak-to-
peak TA MEP amplitude before any intervention. Each graph represents a different day of the 
intervention; session one, session six (after two weeks), and session 12 (after four weeks). G) 
displays mean TA MEP amplitudes (µV) for the associative (black bars) and sham (grey bars) 
intervention groups for pre, post, and post30 measurements, pooled across all sessions and 
stimulation intensities. Note the significant group by time interaction, where MEPs are 
significantly increased at post and post30 measurements for the associative intervention group 
only. Error bars represent standard error and asterisks indicate significant differences. RMT, 
resting motor threshold. 
 
 
